CUMBERLAND PHARMACEUTICALS INC cotiza a 7.00 USD y tiene una capitalización bursátil de $105M. En los últimos 12 meses ha facturado $31M con un margen de flujo de caja libre del 10.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a…
| Periodo | 2026-11 | 2021-08 | 2021-05 | 2021-03 |
|---|---|---|---|---|
| Real | — | — | $0.07 | $0.01 |
| Estimado | — | $-0.07 | $-0.07 | $-0.01 |
| Sorpresa | — | — | +200.0% | +200.0% |
| Métrica | CPIX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 85.0% | 57.0% | +28.0% |
| Operating Margin | -6.3% | -38.6% | +32.3% |
| Net Margin | -6.4% | -33.6% | +27.2% |
| FCF Margin | 10.9% | -13.9% | +24.7% |
| ROE | -11.4% | -40.4% | +29.0% |
| ROA | -3.7% | -32.0% | +28.3% |
| Current Ratio | 1.01 | 2.84 | -1.83 |
| Debt / Equity | — | 0.28 | — |